Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference5 articles.
1. Solerte SB, Di Sabatino A, Galli M, Fiorina P (2020) Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 Acta Diabetol 57:779–783.
2. Hasan SS, Radford S, Kow CS, Zaidi STR (2020) Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis [published online ahead of print, 2020 Aug 3]. J Thromb Thrombolysis 1–8.
3. Maier CL, Truong AD, Auld SC, Polly DM, Tanksley CL, Duncan A (2020) COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? Lancet 395:1758–1759
4. Krijnen PA, Hahn NE, Kholová I et al (2012) Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients. Basic Res Cardiol 107:233
5. Gouverneur A, Lair A, Arnaud M et al (2020) DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database. Lancet Diabetes Endocrinol 8:365–367
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献